LPL Financial’s TherapeuticsMD TXMD Stock Holding History

LPL Financial’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-835	Closed	-$16K	–	4538
2022 Q1	$16K	Buy	835 +36	+5%	+$566	﹤0.01%	4134
2021 Q4	$14K	Buy	799 +100	+14%	+$3K	﹤0.01%	4306
2021 Q3	$26K	Sell	699 -3	-0.4%	-$133	﹤0.01%	4274
2021 Q2	$42K	Buy	702 +28	+4%	+$1.7K	﹤0.01%	4157
2021 Q1	$45K	Buy	+674	New	+$52.8K	﹤0.01%	4000
2020 Q4	–	Sell	-382	Closed	-$30K	–	3868
2020 Q3	$30K	Buy	382 +102	+36%	+$8.13K	﹤0.01%	3479
2020 Q2	$18K	Hold	280	–	–	﹤0.01%	3422
2020 Q1	$15K	Buy	280 +60	+27%	+$5.95K	﹤0.01%	3160
2019 Q4	$27K	Hold	220	–	–	﹤0.01%	3297
2019 Q3	$40K	Buy	+220	New	+$31K	﹤0.01%	3219
2015 Q3	–	Sell	-278	Closed	-$114K	–	2897
2015 Q2	$114K	Buy	+278	New	+$98.1K	﹤0.01%	2737

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

LPL Financial's TXMD Position: Q2 2022 in Review

LPL Financial sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 835 shares — an estimated $16K sold.

LPL Financial first reported a position in TXMD in Q2 2015 and held it in 11 quarters. The position peaked at $114K in Q2 2015. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

LPL Financial reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
LPL Financial sold 835 TherapeuticsMD shares in Q2 2022, an estimated $16K.
LPL Financial first reported a position in TherapeuticsMD in Q2 2015 and held it in 11 quarters.
LPL Financial's TherapeuticsMD position peaked at $114K in Q2 2015.
53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on LPL Financial's 13F filing for Q2 2022, filed 12 Aug 2022.